7TM raises $13.4 million

7TM (Horsholm, Denmark) raised DKK75 million ($13.4 million) in a private round through existing investors. 7TM has two compounds in Phase I/II testing to treat obesity: obinepitide, a synthetic analog of human hormones PYY3-36 and pancreatic polypeptide; and TM30339, a neuropeptide Y receptor Y4 (NPY4R) agonist. ...